Test Price
2,800 AED✅ Home Collection Available
CHRND Gene Myasthenic Syndrome (Congenital, Type 3B, Fast-Channel) Genetic Test in UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytical sensitivity via ISO 9001:2015 certified laboratory processing
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection: Available daily from 8 AM to 11 PM
- Post-Test Consultation: Telephonic consultation with clinical genetics expert to interpret results
- Insurance Verification: Direct verification via WhatsApp at +971 54 548 8731
Test Overview & Methodology
This advanced genetic test uses Next Generation Sequencing (NGS) to analyze the CHRND gene for mutations causing Congenital Myasthenic Syndrome type 3B (fast-channel). It provides definitive molecular confirmation for affected individuals and at-risk family members, guiding tailored treatment and management strategies.
| Feature | Our Test (CHRND NGS) | Closest Alternative |
|---|---|---|
| Diagnostic Precision | Full gene sequencing, detects known and novel variants; 99.9% analytical sensitivity | Single‑gene deletion/duplication tests (e.g., MLPA) – miss point mutations |
| Methodology | NGS (Illumina platform, coverage >100x) | Sanger sequencing of selected exons – limited scope |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that the CHRND NGS test is a powerful diagnostic tool, but results must always be interpreted alongside clinical findings, family history, and electrophysiological studies. A negative result does not rule out the condition if clinical suspicion remains high; variants of uncertain significance require multidisciplinary evaluation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Important Medication Advisory
Do not discontinue prescribed medications such as pyridostigmine or immunosuppressants without consulting your doctor. Abrupt cessation can precipitate a myasthenic crisis. Continue all medications as prescribed.
Exclusion Criteria & Emergency Red Flags
- Not suitable for asymptomatic minors with no family history; predictive genetic testing in children is strictly regulated under UAE health data protection frameworks.
- Avoid testing during acute infection or recent trauma as it may delay sample transport and interpretation.
- Emergency red flags: If the patient develops sudden worsening of muscle weakness, difficulty swallowing/breathing, or stridor, seek immediate emergency medical attention – do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the CHRND gene test and how does NGS improve accuracy?
The CHRND gene test uses Next Generation Sequencing to examine the entire coding region of the CHRND gene, providing near‑perfect detection of single‑nucleotide variants and small insertions/deletions that cause fast‑channel congenital myasthenic syndrome type 3B.
2. Who should consider this test and what does sample collection involve?
Any child or adult with clinical features of early‑onset muscle weakness, ptosis, or respiratory difficulties and a suspected congenital myasthenic syndrome should undergo CHRND NGS testing after genetic counselling. Sample collection is via standard blood draw (EDTA tube) or FTA card; VIP mobile phlebotomy and temperature-controlled cold-chain home collection is available daily from 8 AM to 11 PM.
3. How long do results take and will a doctor explain them?
Results are available in 3–4 weeks, and your package includes a telephonic post‑test consultation with a clinical genetics expert who will interpret the findings in the context of your medical history.
UAE Regulatory & Data Privacy Adherence
This laboratory adheres to the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is handled with the highest confidentiality and security standards.
Clinical & Logistical Metadata
| Test Name | CHRND Gene Myasthenic Syndrome (Congenital, Type 3B, Fast-Channel) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA tube), extracted DNA (≥1 µg), or FTA card. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | Next Generation Sequencing (NGS) on Illumina platform, coverage >100x |
| ICD-10-CM Code | G70.2 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Laboratory: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians